Research Awards

A complete listing of all MRA grant awards, along with abstracts, can be accessed online at CureMelanoma.org/Grants

Pictured: Dr. Stephanie Dougan

Research Awards

A complete listing of all MRA grant awards, along with abstracts, can be accessed online at CureMelanoma.org/Grants

Pictured: Dr. Stephanie Dougan

MRA Snapshot

Since its founding in 2007, the Melanoma Research Alliance has become the largest non-profit funder of melanoma research worldwide. Through 380 awards, MRA has directly invested more than $131 million, and leveraged an additional $415 million in collaborative and follow-on funding towards its mission. MRA is catalyzing strategic, collaborative, and accountable research efforts that have moved the field forward and given patients and their loved ones better treatment options and renewed hope.

To learn more about MRA funded research awards, please visit CureMelanoma.org/Grants

Young Investigator Awards

MRA Young Investigator Awards aim to attract early career scientists with novel ideas into melanoma research, thereby recruiting and supporting the next generation of melanoma researchers. Young Investigators are scientists within four years of their first academic faculty appointment. A mentorship commitment from a senior investigator is required.

Pilot Awards

MRA Pilot Awards test potentially transformative ideas that do not have extensive preliminary data but articulate a clear hypothesis and translational goals. Resources for such “high-risk, high-reward” projects are important to establish proof-of-concept, which may then leverage additional funding through more traditional avenues.

Established Investigator Awards

Established Investigator Awards support senior investigators with an established record of scientific productivity and accomplishment and who are past the initial four years of their first academic faculty appointment.

Dermatology Fellow Awards

MRA Dermatology Fellowship Awards are designed to drive greater interest in the prevention, detection, diagnosis and early intervention of melanoma among dermatologists by investing in post-docs and medical residents focused on dermatology.